The invention relates to a substance which lowers LDL cholesterol levels in
serum and which is fat soluble .beta.-sitostanol fatty acid ester, and to
a method for preparing and using the same. The substance can be taken
orally as a food additive, food substitute or supplement. A daily
consumption of the .beta.-sitostanol ester in an amount between about 0.2
and about 20 g/day has been shown to reduce the absorption of biliary and
endogenic cholesterol.
